Angiotensin receptor blockers for prevention of cardiovascular disease: where does the evidence stand?

Angiotensin receptor blockers (ARBs) are the most commonly used among blood pressure-lowering drugs worldwide, despite the absence of sound evidence of effectiveness in large and unbiased clinical trials. Meta-analyses published in recent years and reviewed here have not given support to this prefer...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuchs, Flávio Danni, DiNicolantonio, James J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Cardiac Risk Factors and Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395832/
https://www.ncbi.nlm.nih.gov/pubmed/25893104
http://dx.doi.org/10.1136/openhrt-2014-000236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395832/
https://www.ncbi.nlm.nih.gov/pubmed/25893104
http://dx.doi.org/10.1136/openhrt-2014-000236

Ejemplares similares